A Pilot comparative study of the efficacy and patient acceptability of the Rapid Rhino tamponade balloon and Merocel nasal tampon in acute epistaxis
| ISRCTN | ISRCTN50635206 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN50635206 |
| Secondary identifying numbers | N0083126301 |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 20/08/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Dominic Martin-Hirsch
Scientific
Scientific
Surgery and Anaesthetics
Calderdale and Huddersfield NHS Trust
Calderdale Royal Hospital
Salterhebble
Halifax
HX3 0PW
United Kingdom
| abc@email.com |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | A Pilot comparative study of the efficacy and patient acceptability of the Rapid Rhino tamponade balloon and Merocel nasal tampon in acute epistaxis |
| Study objectives | There is no difference between the rapid rhino tamponade balloon and the merocel nasal tampon in preventing bleeding from the nose. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Signs and Symptoms: Acute epistaxis |
| Intervention | Rapid rhino tamponade balloon vs merocel nasal tampon |
| Intervention type | Device |
| Pharmaceutical study type(s) | |
| Phase | |
| Drug / device / biological / vaccine name(s) | |
| Primary outcome measure | 1. Time to cessation of bleeding 2. Patient comfort |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 13/03/2003 |
| Completion date | 12/09/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | 126 |
| Key inclusion criteria | 126 patients |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 13/03/2003 |
| Date of final enrolment | 12/09/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Calderdale and Huddersfield NHS Trust
Halifax
HX3 0PW
United Kingdom
HX3 0PW
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.dh.gov.uk/Home/fs/en |
|---|
Funders
Funder type
Government
Calderdale and Huddersfield NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
